Evidence map›Paper›PMID 11971963›Full record

ArticleMolecular and cellular biology2002

c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.

Kiyotsugu Yoshida, Kiyoshi Komatsu, Hong-Gang Wang, Donald Kufe

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 98 citations in OpenAlex.

  1. Parasitic castration by a viral protein tyrosine phosphatase targeting the host cell cycle checkpoint protein Rad9A.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Allosteric regulation of autoinhibition and activation of c-Abl.Computational and structural biotechnology journal · 2022
    Article
  4. Hypermethylation ofEXCLI journal · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Contributions of Rad9 to tumorigenesis.Journal of cellular biochemistry · 2012
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Kiyotsugu YoshidaDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Kiyoshi Komatsu
Hong-Gang Wang
Donald Kufe
Dana-Farber Cancer Institute · USFlorida College · USHarvard University · USMoffitt Cancer Center · US

Funding

MOLECULAR MECHANISMS OF ARA-C THERAPY IN MANR01CA029431 · NCI · DANA-FARBER CANCER INSTITUTE · PI KUFE, DONALD W. · 1985 to 2005
$2.0M
NCI NIH HHS CA29431NCI NIH HHS CA55241
6 · The paper itself

Abstract

The ubiquitously expressed c-Abl tyrosine kinase is activated in the apoptotic response of cells to DNA damage. The mechanisms by which c-Abl signals the induction of apoptosis are not understood. Here we show that c-Abl binds constitutively to the mammalian homolog of the Schizosaccharomyces pombe Rad9 cell cycle checkpoint protein. The SH3 domain of c-Abl interacts directly with the C-terminal region of Rad9. c-Abl phosphorylates the Rad9 Bcl-2 homology 3 domain (Tyr-28) in vitro and in cells exposed to DNA-damaging agents. The results also demonstrate that c-Abl-mediated phosphorylation of Rad9 induces binding of Rad9 to the antiapototic Bcl-x(L) protein. The regulation of Rad9 by c-Abl in the DNA damage response is further supported by the demonstration that the interaction between c-Abl and Rad9 contributes to DNA damage-induced apoptosis. These findings indicate that Rad9 is regulated by a c-Abl-dependent mechanism in the apoptotic response to genotoxic stress.

Indexed as

DNA DamageApoptosisbcl-X ProteinCell Cycle ProteinsCell LineFlow CytometryHumansPhosphorylationProtein BindingProto-Oncogene Proteins c-ablProto-Oncogene Proteins c-bcl-2Recombinant Fusion ProteinsTransfectionTyrosineBCL2L1 protein, humanbcl-X ProteinCell Cycle ProteinsProto-Oncogene Proteins c-ablProto-Oncogene Proteins c-bcl-2rad9 proteinRecombinant Fusion ProteinsTyrosine

Identifiers

PMID11971963
PMCPMC133797
OpenAlexW2144934582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.